PharVision Advisers’s The RMR Group RMR Stock Holding History

PharVision Advisers’s Portfolio RMR Stock Details RMR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-13,047	Closed	-$205K	–	959
2025 Q3	$205K	Buy	+13,047	New	+$218K	0.12%	498

Other funds holding RMR

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

FFL

Flat Footed LLC Wilson, Wyoming $920M AUM 86.47% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

PharVision Advisers's RMR Position: Q4 2025 in Review

PharVision Advisers sold out of The RMR Group (RMR) in Q4 2025, closing a stake of 13,047 shares — an estimated $205K sold.

PharVision Advisers first reported a position in RMR in Q3 2025 and held it in 1 quarter. The position peaked at $205K in Q3 2025. 168 funds tracked by Wall St. Rank hold RMR as of Q4 2025.

PharVision Advisers reported no remaining The RMR Group position as of Q4 2025 after selling out during the quarter.
PharVision Advisers sold 13,047 The RMR Group shares in Q4 2025, an estimated $205K.
PharVision Advisers first reported a position in The RMR Group in Q3 2025 and held it in 1 quarter.
PharVision Advisers's The RMR Group position peaked at $205K in Q3 2025.
168 funds tracked by Wall St. Rank held The RMR Group as of Q4 2025.

Based on PharVision Advisers's 13F filing for Q4 2025, filed 17 Feb 2026.